Literature DB >> 27072391

Detection and characterization of breast lesions in a selective diagnostic population: diagnostic accuracy study for comparison between one-view digital breast tomosynthesis and two-view full-field digital mammography.

Eun Young Chae1, Hak Hee Kim1, Joo Hee Cha1, Hee Jung Shin1, Woo Jung Choi1.   

Abstract

OBJECTIVE: To compare the performance of one-view digital breast tomosynthesis (DBT) and two-view full-field digital mammography (FFDM) in the detection and characterization of breast lesions in a selective diagnostic population.
METHODS: A total of 598 breasts of 319 diagnostic patients were prospectively enrolled. Participants underwent bilateral one-view, mediolateral oblique (MLO) DBT and two-view, craniocaudal and MLO FFDM. The sensitivity and specificity of these methods and their classification into correct Breast Imaging-Reporting and Data System (BI-RADS) categories were compared. These methods were also compared in patients subgrouped by mammographic parenchymal density. Receiver operating characteristic (ROC) curve analysis was performed using the probability of cancer scores.
RESULTS: DBT had higher overall sensitivity than FFDM (88.7% vs 80.7%, p = 0.001). Subgroup analyses showed that DBT had significantly higher sensitivity in assessing dense breasts and invasive cancers than FFDM. The BI-RADS category assessment was significantly better for DBT than for FFDM. The differences between the two modalities in specificity (94.1% and 93.2% for FFDM and DBT) were not significant (p = 0.664). The area under the ROC curves using the probability of cancer scores were 0.93 [95% confidence interval (CI), 0.91-0.95] for FFDM and 0.96 (95% CI, 0.94-0.97) for DBT (p = 0.005). ROC curve analysis indicated that most of the increased performance of DBT was due to dense breasts.
CONCLUSION: A beneficial effect on the detection and characterization of breast lesions was found for one-view DBT compared with two-view FFDM in a selective diagnostic population. Improvements were especially enhanced in females with dense breasts. These results need to be examined in studies using large-scale consecutive sampling of a diagnostic population. ADVANCES IN KNOWLEDGE: In this study, using selective diagnostic study cases, one-view DBT offered improved reader performance compared with two-view FFDM for detection and characterization of breast cancers.

Entities:  

Mesh:

Year:  2016        PMID: 27072391      PMCID: PMC5258147          DOI: 10.1259/bjr.20150743

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  27 in total

1.  Quantitative assessment of mammographic breast density: relationship with breast cancer risk.

Authors:  Jennifer A Harvey; Viktor E Bovbjerg
Journal:  Radiology       Date:  2003-11-14       Impact factor: 11.105

2.  Two-view and single-view tomosynthesis versus full-field digital mammography: high-resolution X-ray imaging observer study.

Authors:  Matthew G Wallis; Elin Moa; Federica Zanca; Karin Leifland; Mats Danielsson
Journal:  Radiology       Date:  2012-01-24       Impact factor: 11.105

3.  Digital breast tomosynthesis is comparable to mammographic spot views for mass characterization.

Authors:  Mitra Noroozian; Lubomir Hadjiiski; Sahand Rahnama-Moghadam; Katherine A Klein; Deborah O Jeffries; Renee W Pinsky; Heang-Ping Chan; Paul L Carson; Mark A Helvie; Marilyn A Roubidoux
Journal:  Radiology       Date:  2011-10-13       Impact factor: 11.105

Review 4.  Digital mammography: novel applications.

Authors:  Elizabeth A Rafferty
Journal:  Radiol Clin North Am       Date:  2007-09       Impact factor: 2.303

5.  Digital breast tomosynthesis versus supplemental diagnostic mammographic views for evaluation of noncalcified breast lesions.

Authors:  Margarita L Zuley; Andriy I Bandos; Marie A Ganott; Jules H Sumkin; Amy E Kelly; Victor J Catullo; Grace Y Rathfon; Amy H Lu; David Gur
Journal:  Radiology       Date:  2012-11-09       Impact factor: 11.105

6.  Digital breast tomosynthesis versus full-field digital mammography: comparison of the accuracy of lesion measurement and characterization using specimens.

Authors:  Nieun Seo; Hak Hee Kim; Hee Jung Shin; Joo Hee Cha; Hyunji Kim; Jin Hee Moon; Gyungyub Gong; Sei-Hyun Ahn; Byung Ho Son
Journal:  Acta Radiol       Date:  2013-09-04       Impact factor: 1.990

7.  Combination of one-view digital breast tomosynthesis with one-view digital mammography versus standard two-view digital mammography: per lesion analysis.

Authors:  Gisella Gennaro; R Edward Hendrick; Alicia Toledano; Jean R Paquelet; Elisabetta Bezzon; Roberta Chersevani; Cosimo di Maggio; Manuela La Grassa; Luigi Pescarini; Ilaria Polico; Alessandro Proietti; Enrica Baldan; Fabio Pomerri; Pier Carlo Muzzio
Journal:  Eur Radiol       Date:  2013-04-26       Impact factor: 5.315

8.  Value of one-view breast tomosynthesis versus two-view mammography in diagnostic workup of women with clinical signs and symptoms and in women recalled from screening.

Authors:  Christian Waldherr; Peter Cerny; Hans J Altermatt; Gilles Berclaz; Michele Ciriolo; Katharina Buser; Martin J Sonnenschein
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

9.  Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Mark Helfand; Benjamin K S Chan; Steven H Woolf
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

10.  Analysis of cancers missed at screening mammography.

Authors:  R E Bird; T W Wallace; B C Yankaskas
Journal:  Radiology       Date:  1992-09       Impact factor: 11.105

View more
  7 in total

1.  Decrease in interpretation time for both novice and experienced readers using a concurrent computer-aided detection system for digital breast tomosynthesis.

Authors:  Eun Young Chae; Hak Hee Kim; Ji-Wook Jeong; Seung-Hoon Chae; Sooyeul Lee; Young-Wook Choi
Journal:  Eur Radiol       Date:  2018-12-13       Impact factor: 5.315

2.  Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic?

Authors:  S Mall; J Noakes; M Kossoff; W Lee; M McKessar; A Goy; J Duncombe; M Roberts; B Giuffre; A Miller; N Bhola; C Kapoor; C Shearman; G DaCosta; S Choi; J Sterba; M Kay; K Bruderlin; N Winarta; K Donohue; B Macdonell-Scott; F Klijnsma; K Suzuki; P Brennan; C Mello-Thoms
Journal:  Eur Radiol       Date:  2018-05-30       Impact factor: 5.315

Review 3.  Comparison of Diagnostic Test Accuracy of Cone-Beam Breast Computed Tomography and Digital Breast Tomosynthesis for Breast Cancer: A Systematic Review and Meta-Analysis Approach.

Authors:  Temitope Emmanuel Komolafe; Cheng Zhang; Oluwatosin Atinuke Olagbaju; Gang Yuan; Qiang Du; Ming Li; Jian Zheng; Xiaodong Yang
Journal:  Sensors (Basel)       Date:  2022-05-09       Impact factor: 3.847

4.  Digital breast tomosynthesis: sensitivity for cancer in younger symptomatic women.

Authors:  Patsy Whelehan; Kulsam Ali; Sarah Vinnicombe; Graham Ball; Julie Cox; Paul Farry; Maggie Jenkin; Keith Lowry; Stuart A McIntosh; Rachel Nutt; Rachel Oeppen; Michael Reilly; Michaela Stahnke; Jim Steel; Yee Ting Sim; Violet Warwick; Louise Wilkinson; Dimitrios Zafeiris; Andrew J Evans
Journal:  Br J Radiol       Date:  2021-01-07       Impact factor: 3.039

Review 5.  The role of digital breast tomosynthesis in the breast assessment clinic: a review.

Authors:  Suneeta Mall; Sarah Lewis; Patrick Brennan; Jennie Noakes; Claudia Mello-Thoms
Journal:  J Med Radiat Sci       Date:  2017-04-04

Review 6.  The role of digital breast tomosynthesis in breast cancer screening: a manufacturer- and metrics-specific analysis.

Authors:  A Hadjipanteli; M Kontos; A Constantinidou
Journal:  Cancer Manag Res       Date:  2019-10-31       Impact factor: 3.989

Review 7.  Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts - a systematic review and meta-analysis.

Authors:  Xuan-Anh Phi; Alberto Tagliafico; Nehmat Houssami; Marcel J W Greuter; Geertruida H de Bock
Journal:  BMC Cancer       Date:  2018-04-03       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.